Canada markets closed

HeraMED Limited (HMD.AX)

ASX - ASX Delayed Price. Currency in AUD
Add to watchlist
0.01600.0000 (0.00%)
At close: 02:41PM AEST
Currency in AUD

Valuation Measures4

Market Cap (intraday) 6.69M
Enterprise Value 5.91M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)7.48
Price/Book (mrq)9.53
Enterprise Value/Revenue 9.77
Enterprise Value/EBITDA -8.26

Trading Information

Stock Price History

Beta (5Y Monthly) 0.04
52-Week Change 3-76.83%
S&P500 52-Week Change 323.23%
52 Week High 30.0910
52 Week Low 30.0120
50-Day Moving Average 30.0171
200-Day Moving Average 30.0320

Share Statistics

Avg Vol (3 month) 3382.89k
Avg Vol (10 day) 3583.46k
Shares Outstanding 5393.25M
Implied Shares Outstanding 6393.25M
Float 8263.85M
% Held by Insiders 129.37%
% Held by Institutions 11.07%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,117.49%

Management Effectiveness

Return on Assets (ttm)-89.78%
Return on Equity (ttm)-270.58%

Income Statement

Revenue (ttm)402.9k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)155.40%
Gross Profit (ttm)N/A
EBITDA -4.38M
Net Income Avi to Common (ttm)-4.5M
Diluted EPS (ttm)-0.0200
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)752.72k
Total Cash Per Share (mrq)0
Total Debt (mrq)177.86k
Total Debt/Equity (mrq)38.11%
Current Ratio (mrq)1.28
Book Value Per Share (mrq)0.00

Cash Flow Statement

Operating Cash Flow (ttm)-3.8M
Levered Free Cash Flow (ttm)-2.23M